IDH1 and glioblastoma: Overall, despite the presence of EGFR amplification in all four cases, a diagnostic molecular marker in IDH-wildtype glioblastoma and a predictor of its aggressive behavior, IDH-mutant status was the determinate factor for an epigenetics-based classification of these high-grade astrocytomas.